ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Roswell Park Researchers Win $1.6M For Tobacco Studies.

June 20, 2003

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Harold Freeman To Direct NCI Center To Reduce Cancer Health Disparities.

September 15, 2000

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Funding opportunities listed.

October 29, 2004

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996